the reimbursement of Velcade® (bortezomib) should be requested through eHealth as of 1/5/2018. In addition, the Velcade list price 3,5 mg and 1 mg has been decreased.
For more information, please download the official communication.
Updated Velcade RMA materials (RMA: risk minimisation activities) are now available. The RMP includes the necessary measures to guarantee safe and effective use of Velcade and includes following documents for health care professionals (HCP):